Abstract:Cytokeratin 19 (CK19) is a complex intracytoplasmic cytoskeletal protein primarily localized in the ducts of the mammary gland and skin epithelial cells. In humans, the expression of CK19 gene within circulating tumor cells (CTCs) extracted from blood samples of breast cancer patients reflects tumor cell activity, offering valuable insights for predicting early metastatic relapse or monitoring treatment effectiveness. However, knowledge of serum tumor markers is limited in veterinary oncology. Recently, droplet digital PCR (ddPCR), has been employed to explore rare target genes due to its heightened sensitivity and accuracy as a novel molecular diagnostic tool. The objectives of this study were to investigate the expression of the CK19 mRNA in CTCs, non-neoplastic mammary tissues, and both benign and malignant canine mammary tumors (CMTs) through ddPCR analysis. In Study I, we optimized the discard volume for blood samples to reduce CK19 contamination from skin epithelial cells post-venipuncture. The results revealed that discarding the initial 3 mL of blood was adequate and effective in eliminating CK19 mRNA contamination. In Study II, after the removal of the initial 3 mL of blood, we investigated CK19 mRNA-positive CTCs in the peripheral blood of normal healthy dogs, including those with benign and malignant CMTs. Intriguingly, CK19 mRNA was undetectable in all blood samples. The expression of CK19 mRNA in mammary tissues was investigated in Study III. The copy number (CN) ratios of the CK19 gene in non-neoplastic mammary tissues (14.77 ± 14.65) were significantly higher (P < 0.05) than those in benign (4.23 ± 3.35) and malignant groups (6.56 ± 5.64). Notably, no difference was observed between the benign and malignant groups. In conclusion, CK19 mRNA appeared unlikely to be a suitable candidate as a biomarker in the peripheral blood of CMTs, while the CN ratio in mammary tissues could serve as a potential discriminator between non-neoplastic and CMT groups, complementing the gold standard of histopathological examination.

The Analysis of E-Cadherin, N-Cadherin, Vimentin, HER-2, CEA, CA15-3 and SF Expression in the Diagnosis of Canine Mammary Tumors.

Diagnosis of Canine Tumours and the Value of Combined Detection of VEGF, P53, SF and NLRP3 for the Early Diagnosis of Canine Mammary Carcinoma

Clinico-Pathological, Immunohistochemical and In-Situ TUNEL ASSAY Observations of Canine Breast Tumors

Combined detection of CA15-3, CEA, and SF in serum and tissue of canine mammary gland tumor patients

Quantification of VEGF-C Gene Expression in Canine Mammary Tumors by Real-Time Reverse Transcription Quantitative Polymerase Chain Reaction

Evaluation Of Expression Of The Wnt Signaling Components In Canine Mammary Tumors Via Rt2 Profiler Pcr Array And Immunochemistry Assays

Quantification of VEGF-C Expression in Canine Mammary Tumours.

Integrated Study of Canine Mammary Tumors Histopathology, Immunohistochemistry, and Cytogenetic Findings

Microsatellite Instability and MMR Genes Abnormalities in Canine Mammary Gland Tumors

Research progress of good markers for canine mammary carcinoma

Expression and Significance of IL-6 and IL-8 in Canine Mammary Gland Tumors

PD-L1 mRNA and protein expression in canine mammary carcinomas: Correlation with histopathological grade and molecular markers

Potential Biomarkers of Malignancy in Canine Mammary Neoplasia

Relation between expressions of PTEN and VEGF and clinicopathological features in canine mammary gland tumors

Novel promising serum biomarkers for canine mammary tumors

Histopathological observations of canine mammary gland tumors and expression analysis of tenascin-C

Proteomic analysis of extracellular vesicles derived from canine mammary tumour cell lines identifies protein signatures specific for disease state

Expression and Prognosis of Hexokinase 2 in Canine Mammary Tumors

Advancing canine mammary tumor diagnostics: Unraveling the diagnostic potential of Cytokeratin 19 through droplet digital PCR analysis

Canine Mammary Tumors as a Potential Model for Human Breast Cancer in Comparative Oncology

Epidemiological Investigation of Canine Mammary Tumors in Mainland China Between 2017 and 2021